Journal of Medical Economics, Volume 23, Issue 4 (2020)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Journal of Medical Economics, Volume 23, Issue 4 (2020)

See all volumes and issues
Vol 27, 2024 Vol 26, 2023 Vol 25, 2022 Vol 24, 2021 Volume 23, 2020 Vol 22, 2019 Vol 21, 2018 Vol 20, 2017 Vol 19, 2016 Vol 18, 2015 Vol 17, 2014 Vol 16, 2013 Vol 15, 2012 Vol 14, 2011 Vol 13, 2010 Vol 12, 2009 Vol 11, 2008 Vol 10, 2007 Vol 9, 2006 Vol 8, 2005 Vol 7, 2004 Vol 6, 2003 Vol 5, 2002 Vol 4, 2001 Vol 3, 2000 Vol 2, 1999 Vol 1, 1998
Download citations Download PDFs Download issue

Health Policy

Review
Health technology assessment in Japan: a work in progress
Isao Kamae, Rob Thwaites, Anna Hamada & Jovelle L. Fernandez
Pages: 317-322
Published online: 29 Jan 2020
AbstractforHealth technology assessment in Japan: a work in progress | Full Text | References | PDF (606.6 KB) | EPUB
  • 16337 Views
  • 19 CrossRef citations
  • 0Altmetric
Open Access

Oncology

Article
Healthcare resource utilization and costs associated with venous thromboembolism recurrence in patients with cancer
Alok A. Khorana, Keith R. McCrae, Dejan Milentijevic, François Laliberté, Dominique Lejeune, Concetta Crivera & Patrick Lefebvre
Pages: 323-329
Published online: 11 Jan 2020
AbstractforHealthcare resource utilization and costs associated with venous thromboembolism recurrence in patients with cancer | Full Text | References | PDF (959.6 KB) | EPUB
  • 1693 Views
  • 5 CrossRef citations
  • 0Altmetric
Open Access
Article
Real-world incidence and burden of adverse events among non-metastatic prostate cancer patients treated with secondary hormonal therapies following androgen deprivation therapy
Anuj Shah, Ruchit Shah, Nehemiah Kebede, Ateesha Mohamed, Marc Botteman, Reg Waldeck & Arif Hussain
Pages: 330-346
Published online: 06 Jan 2020
AbstractforReal-world incidence and burden of adverse events among non-metastatic prostate cancer patients treated with secondary hormonal therapies following androgen deprivation therapy | Full Text | References | PDF (2 MB) | EPUB
  • 5437 Views
  • 15 CrossRef citations
  • 0Altmetric
Open Access
Article
Cost-effectiveness analysis of ramucirumab treatment for patients with hepatocellular carcinoma who progressed on sorafenib with α-fetoprotein concentrations of at least 400 ng/ml
Hanrui Zheng, Zhou Qin, Xingjian Qiu, Mei Zhan, Feng Wen & Ting Xu
Pages: 347-352
Published online: 06 Jan 2020
AbstractforCost-effectiveness analysis of ramucirumab treatment for patients with hepatocellular carcinoma who progressed on sorafenib with α-fetoprotein concentrations of at least 400 ng/ml | Full Text | References | PDF (700.7 KB) | EPUB
  • 1415 Views
  • 8 CrossRef citations
  • 0Altmetric
Free Access

Rheumatology

Article
A cost-effectiveness and budget impact analysis of apremilast in patients with psoriatic arthritis in Italy
Stefano Capri, A. Migliore, F. Loconsole & Marco Barbieri
Pages: 353-361
Published online: 31 Dec 2019
AbstractforA cost-effectiveness and budget impact analysis of apremilast in patients with psoriatic arthritis in Italy | Full Text | References | PDF (1.2 MB) | EPUB | Supplemental
  • 1231 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access
Article
A cost-effectiveness and budget impact analysis of apremilast in patients with psoriasis in the Italian setting
Marco Barbieri, F. Loconsole, A. Migliore & S. Capri
Pages: 362-370
Published online: 20 Jan 2020
AbstractforA cost-effectiveness and budget impact analysis of apremilast in patients with psoriasis in the Italian setting | Full Text | References | PDF (1 MB) | EPUB | Supplemental
  • 1484 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access

Women's Health

Article
Healthcare utilization and cost burden among women with endometriosis by opioid prescription status in the first year after diagnosis: a retrospective claims database analysis
S. As-Sanie, A. M. Soliman, K. Evans, N. Erpelding, R. Lanier & NP Katz
Pages: 371-377
Published online: 11 Jan 2020
AbstractforHealthcare utilization and cost burden among women with endometriosis by opioid prescription status in the first year after diagnosis: a retrospective claims database analysis | Full Text | References | PDF (634.5 KB) | EPUB | Supplemental
  • 1686 Views
  • 14 CrossRef citations
  • 0Altmetric
Free Access

Hepatology

Article
The burden associated with thrombocytopenia and platelet transfusions among patients with chronic liver disease
Mohamed I. Elsaid, Vinod K. Rustgi, Nicole Loo, Kavita Aggarwal, Josephine Li-McLeod, Xiaoli Niu & Fred Poordad
Pages: 378-385
Published online: 15 Dec 2019
AbstractforThe burden associated with thrombocytopenia and platelet transfusions among patients with chronic liver disease | Full Text | References | PDF (685 KB) | EPUB
  • 2347 Views
  • 4 CrossRef citations
  • 0Altmetric
Open Access

Cardiovascular

Article
Cost-effectiveness of targeted screening for the identification of patients with atrial fibrillation: evaluation of a machine learning risk prediction algorithm
Nathan R. Hill, Belinda Sandler, Ruth Mokgokong, Steven Lister, Thomas Ward, Rebecca Boyce, Usman Farooqui & Jason Gordon
Pages: 386-393
Published online: 10 Jan 2020
AbstractforCost-effectiveness of targeted screening for the identification of patients with atrial fibrillation: evaluation of a machine learning risk prediction algorithm | Full Text | References | PDF (1.4 MB) | EPUB | Supplemental
  • 4276 Views
  • 15 CrossRef citations
  • 0Altmetric
Open Access
Article
Economic evaluation of olmesartan/amlodipine fixed-dose combination for hypertension treatment in China
Maodong Ren, Dennis Xuan, Yongji Lu, YuYan Fu & Jianwei Xuan
Pages: 394-400
Published online: 25 Jan 2020
AbstractforEconomic evaluation of olmesartan/amlodipine fixed-dose combination for hypertension treatment in China | Full Text | References | PDF (709.2 KB) | EPUB | Supplemental
  • 2330 Views
  • 7 CrossRef citations
  • 0Altmetric
Free Access

Diabetes

Article
Real-world comparison of hospitalization costs for heart failure in type 2 diabetes mellitus patients with established cardiovascular disease treated with canagliflozin versus other antihyperglycemic agents
Yen-Wen Chen, Jennifer Voelker, Ozgur Tunceli, Christopher D. Pericone, Brahim Bookhart & Michael Durkin
Pages: 401-406
Published online: 04 Dec 2019
AbstractforReal-world comparison of hospitalization costs for heart failure in type 2 diabetes mellitus patients with established cardiovascular disease treated with canagliflozin versus other antihyperglycemic agents | Full Text | References | PDF (582.9 KB) | EPUB
  • 2926 Views
  • 2 CrossRef citations
  • 0Altmetric
Open Access

Endocrinology

Article
Treatment patterns, health resource utilization and costs among central precocious puberty patients treated with leuprolide or histrelin: an examination of the commercial and Medicaid populations
Karen O. Klein, Ahmed M. Soliman, Machaon Bonafede, James K. Nelson & Elizabeth Grubb
Pages: 407-414
Published online: 09 Dec 2019
AbstractforTreatment patterns, health resource utilization and costs among central precocious puberty patients treated with leuprolide or histrelin: an examination of the commercial and Medicaid populations | Full Text | References | PDF (986.5 KB) | EPUB
  • 2068 Views
  • 4 CrossRef citations
  • 0Altmetric
Open Access

Gastroenterology

Article
Living with ulcerative colitis in Germany: a retrospective analysis of dose escalation, concomitant treatment use and healthcare costs
Axel Dignass, John Waller, Joseph C. Cappelleri, Irene Modesto, Agnes Kisser, Lena Dietz, Marco DiBonaventura, Robert Wood, Melanie May, Berit Libutzki & Danielle Bargo
Pages: 415-427
Published online: 15 Jan 2020
AbstractforLiving with ulcerative colitis in Germany: a retrospective analysis of dose escalation, concomitant treatment use and healthcare costs | Full Text | References | PDF (1.8 MB) | EPUB
  • 4703 Views
  • 9 CrossRef citations
  • 0Altmetric
Open Access

Explore articles

Explore the most recently published articles

Cost-effectiveness of the RefluxStop device for management of refractory gastroesophageal reflux disease in Switzerland
Sam Harper et al.
Article | Published online: 31 May 2024
Open Access
The efficiency of TAVI in intermediate and low-risk Japanese patients.
Panagiotis Petrou
Editorial | Published online: 25 May 2024
Open Access
Cost-effectiveness of empagliflozin as add-on to standard of care for chronic kidney disease management in the United Kingdom
Mafalda Ramos et al.
Article | Published online: 17 May 2024
Open Access
Estimated impact and value of blood-based colorectal cancer screening at varied adherence compared with stool-based screening
John B. Kisiel et al.
Article | Published online: 13 May 2024
Open Access
View all latest articles